Patent details

EP3368017 Title: OPTIMIZED HIGH-DOSE TABLET OF MESALAZINE

Basic Information

Publication number:
EP3368017
PCT Application Number:
EP2016075427
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167877901
PCT Publication Number:
WO2017072050
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
OPTIMIZED HIGH-DOSE TABLET OF MESALAZINE
French Title of Invention:
COMPRIMÉ OPTIMISÉ A UNE HAUTE DOSE CONTENANT DE LA MESALAZINE
German Title of Invention:
OPTIMIERTE MESALAZINHALTIGE HOCHDOSISTABLETTE
SPC Number:

Dates

Filing date:
21/10/2016
Grant date:
06/11/2019
EP Publication Date:
05/09/2018
PCT Publication Date:
04/05/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/11/2019
EP B1 Publication Date:
06/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/10/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/10/2019
 
 

Name:
Dr. Falk Pharma GmbH
Address:
Leinenweberstrasse 5, 79108 Freiburg, Germany (DE)

Inventor

1

Name:
PRÖLS, Markus
Address:
Germany (DE)

2

Name:
GREINWALD, Roland
Address:
Germany (DE)

3

Name:
NACAK, Tanju
Address:
Germany (DE)

4

Name:
WILHELM, Rudolph
Address:
Germany (DE)

Priority

Priority Number:
15192269
Priority Date:
30/10/2015
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/20; A61K 9/28; A61K 31/606;

Publication

European Patent Bulletin

Issue number:
201945
Publication date:
06/11/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
22/10/2024
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
PAVIS PAYMENTS GMBH
Filing date Document type Number of pages